AR121916A1 - SYSTEMS AND METHODS TO COORDINATE THE MANUFACTURING OF CELLS FOR PATIENT-SPECIFIC IMMUNOTHERAPY - Google Patents
SYSTEMS AND METHODS TO COORDINATE THE MANUFACTURING OF CELLS FOR PATIENT-SPECIFIC IMMUNOTHERAPYInfo
- Publication number
- AR121916A1 AR121916A1 ARP210101085A ARP210101085A AR121916A1 AR 121916 A1 AR121916 A1 AR 121916A1 AR P210101085 A ARP210101085 A AR P210101085A AR P210101085 A ARP210101085 A AR P210101085A AR 121916 A1 AR121916 A1 AR 121916A1
- Authority
- AR
- Argentina
- Prior art keywords
- patient
- therapy product
- cell therapy
- cell
- time point
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Un método para coordinar la fabricación de un producto de terapia celular expandido para un paciente puede incluir recibir una solicitud de pedido de células para expandir el producto de terapia celular para el paciente; generar un identificador específico del paciente o un identificador de orden de célula asociado con la solicitud de orden de célula; e iniciar un proceso para expandir el producto de terapia celular de al menos parte de un tumor sólido obtenido del paciente. Si los parámetros de aceptación para el producto de terapia celular de expansión no cumplen con ciertos criterios de aceptación en un segundo momento posterior al primer momento en el proceso de expansión, se determina si se vuelve a realizar la expansión del producto de terapia celular usando la técnica de expansión celular es posible desde el primer punto de tiempo basado en los parámetros de aceptación en el segundo punto de tiempo. Si es posible repetir la expansión, los eventos de tratamiento del paciente que utilizan el producto de terapia celular expandida se reprograman.A method of coordinating the manufacture of an expanded cell therapy product for a patient may include receiving an order request for cells to expand the cell therapy product for the patient; generating a patient specific identifier or a cell order identifier associated with the cell order request; and initiating a process to expand the cell therapy product from at least part of a solid tumor obtained from the patient. If the acceptance parameters for the expansion cell therapy product do not meet certain acceptance criteria at a second time point after the first time point in the expansion process, it is determined whether to re-expand the cell therapy product using the Cell expansion technique is possible from the first time point based on the acceptance parameters at the second time point. If repeat expansion is possible, the patient's treatment events using the expanded cell therapy product are rescheduled.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063013942P | 2020-04-22 | 2020-04-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR121916A1 true AR121916A1 (en) | 2022-07-20 |
Family
ID=83218651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210101085A AR121916A1 (en) | 2020-04-22 | 2021-04-22 | SYSTEMS AND METHODS TO COORDINATE THE MANUFACTURING OF CELLS FOR PATIENT-SPECIFIC IMMUNOTHERAPY |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR121916A1 (en) |
-
2021
- 2021-04-22 AR ARP210101085A patent/AR121916A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022013065A (en) | Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy. | |
| EP1504403A4 (en) | Tomographic reconstruction of small objects using "a priori" knowledge | |
| DE69617440T2 (en) | ISOLATED NUCLEIC ACID MOLECULES, PEPTIDES COMPLEX WITH HLA-A2 MOLECULES (MHC), AND THEIR USE | |
| AR074564A2 (en) | NUCLEIC ACID CODIFYING AN ANTI-IGFR HUMAN NEUTRALIZING ANTIBODY, RECOMBINING VECTOR CONTAINING IT, GUEST CELL AND METHOD TO PRODUCE THE POLYPEPTIDE | |
| ATE307593T1 (en) | PROGESTIN CO-MICRONIZED WITH A SURFACTANT, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, METHOD FOR THE PRODUCTION AND USE THEREOF | |
| ES2093778T3 (en) | NEW ANTIBODIES AND METHODS FOR USE. | |
| BR8207918A (en) | SURGICAL CLIP AND APPLIANCE FOR THE SAME APPLICATION | |
| MX2020005908A (en) | Process for producing a composition of engineered t cells. | |
| DE69431438D1 (en) | OPEN-POROUSLY IMPLANTABLE PROSTHESIS WITH A STRUCTURED SURFACE AND METHOD FOR THEIR PRODUCTION | |
| NO20014491L (en) | Approach | |
| AR121916A1 (en) | SYSTEMS AND METHODS TO COORDINATE THE MANUFACTURING OF CELLS FOR PATIENT-SPECIFIC IMMUNOTHERAPY | |
| AR010341A1 (en) | PHARMACOLOGICALLY CONTROLLABLE SELF-INTENSIFYING NUCLEIC ACID CONSTRUCT, A PROCESS TO PREPARE SUCH A CONSTRUCTION, VECTOR AND CELL THAT LOCOMPREND AND USE THE SAME AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES THE NUCLEIC ACID CONSTRUCTION AND A METHOD FOR PREPARING THE COMPOSITE | |
| BR112022003852A2 (en) | Methods of preparing t cells for t cell therapy | |
| EA202091841A1 (en) | OSIMERTINIB FOR NON-SMALL CELL LUNG CANCER TREATMENT | |
| BR112023007922A2 (en) | METHOD OF GENERATING TUMOR INFILTRATING LYMPHOCYTES, METHOD OF EXPANDING A POPULATION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) OR MARROW INFILTRATING LYMPHOCYTES (MILS) AND METHODS OF TREATMENT OF CANCER IN A SUBJECT | |
| WO2023077015A3 (en) | Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy | |
| ATE366525T1 (en) | SOLE AND MANUFACTURING PROCESS | |
| RU2015144511A (en) | YEAST IMMUNOTHERAPY OF THE CHORDOMA | |
| WO2022229884A3 (en) | Recombinant antigen presenting cells | |
| WO2020161139A3 (en) | Method of producing ions and apparatus | |
| Da-Yuan | Mathematical principle of planar Z-plasty | |
| Jingtao et al. | The elevated preoperative neutrophil lymphocyte ratio predicts poor survival outcome in breast cancer patients | |
| Winnicott et al. | A Note on a Case Involving Envy: Dated January 1963 | |
| Sefrioui et al. | Immunotherapy of patients with repeated implantation failures in randomized controlled design and its impact on luteal progesterone synthesis | |
| NO20022276L (en) | Placental human neurokinin B precursor |